Results 61 to 70 of about 850,055 (258)

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention

BMC Cardiovascular Disorders, 2009
Background Restenosis represents the major limiting factor for the long-term efficacy of percutaneous coronary intervention (PCI). Several genetic factors involved in the regulation of the vascular system have been described to play a role in the ...
Lankisch Mark, Haltern Georg, Huge Andreas, Rackebrandt Kirsten, Binner Priska, Kullmann Silke, Füth Reiner, von Hodenberg Eberhard, Bestehorn Hans-Peter, Scheffold Thomas   +9 more
doaj   +1 more source

Safety and efficacy of enoxaparin versus unfractionated heparins in conservatively managed patients with acute coronary syndrome: a systematic review

Journal of Pharmacy Practice and Research, EarlyView.
Abstract Aim Guidelines recommend initial anticoagulant management of acute coronary syndrome (ACS) with low molecular weight heparin (LMWH) such as enoxaparin or unfractionated heparin (UFH). Systematic reviews evaluate early trials in the context of multiple other medications or during percutaneous coronary intervention (PCI) only.
Krishna Doshi, Mark Jones, Laetitia Hattingh   +2 more
wiley   +1 more source

Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management

Medicinal Research Reviews, EarlyView.
ABSTRACT Neurodegenerative disorders, including Alzheimer's disease (AD), impose a significant burden on society due to their progressive nature and the associated healthcare costs. Autophagy, a vital cellular degradation process, has emerged as a promising therapeutic target in these disorders.
Baljinder Singh, Shubham Mahajan, Sadikalmahdi Abdella, Rehan Khan, Sanjay Garg   +4 more
wiley   +1 more source

Intractable coronary fibromuscular dysplasia leading to end‐stage heart failure and fatal heart transplantation

ESC Heart Failure, 2020
Coronary fibromuscular dysplasia is uncommon, and even rarer its unstable and recurrent course. We present the unique case of a 52‐year‐old woman who underwent in total 12 coronary angiographies and three percutaneous coronary intervention within 24 ...
Magdalena Maria Cattaneo, Marco Moccetti, Mattia Cattaneo, Daniel Sürder, Thomas Suter, Michele Martinelli, Eva Roost, Jürg Schmidli, Yara Banz, Carmen Schneiders, Giovanni Pedrazzini, Roberto Corti, Lorenz Räber, Filippo Crea, Paul Mohacsi, Augusto Gallino   +15 more
doaj   +1 more source

The Current State of MicroRNAs as Restenosis Biomarkers

Frontiers in Genetics, 2020
In-stent restenosis corresponds to the diameter reduction of coronary vessels following percutaneous coronary intervention (PCI), an invasive procedure in which a stent is deployed into the coronary arteries, producing profuse neointimal hyperplasia. The
Nelson Varela, Fernando Lanas, Fernando Lanas, Luis A. Salazar, Tomás Zambrano   +4 more
doaj   +1 more source

Role of Histone Deacetylase and Inhibitors in Cardiovascular Diseases

Cell Proliferation, EarlyView.
HDACs play an important role in the occurrence and development of cardiovascular diseases, such as myocardial hypertrophy, hypertension, and atherosclerosis. HDAC inhibitors have broad prospects for the treatment of CVD, and different HDAC subtypes can act through different mechanisms.
Li‐Ying Zhang, Yue‐Yue Wang, Ri Wen, Tie‐Ning Zhang, Ni Yang   +4 more
wiley   +1 more source

Impact of Immunosuppressive Drugs on Patients With Percutaneous Left Atrial Appendage Occlusion

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction Percutaneous left atrial appendage closure (LAAC) reduces the risk of thromboembolic stroke in patients with non‐valvular atrial fibrillation who cannot tolerate long‐term oral anticoagulation. However, outcomes after LAAC in patients requiring chronic immunosuppressive therapy (IMS) remain unknown. This study aimed to investigate
Daisuke Togashi, Christopher R. Ellis, Zachary T. Yoneda, Jackon G. Gregory, Shunsuke Uetake, Salah H. Alahwany, Michael T. Baker, Arvindh N. Kanagasundram   +7 more
wiley   +1 more source

Cytomegalovirus Infection and Coronary Restenosis [PDF]

Circulation, 1999
Current techniques of percutaneous transluminal coronary revascularization remain limited by the phenomenon of restenosis. The response of the vessel wall to the iatrogenic injury associated with coronary interventions is a complex and multifactorial process. Experimental and clinical studies suggest that a combination of different mechanisms, such as (
Michel E. Bertrand, Christophe Bauters
openaire   +2 more sources

Prediction of Coronary Artery Restenosis in Patients Undergoing Angioplasty

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2018
BACKGROUND AND OBJECTIVE: Coronary artery restenosis following angioplasty may lead to major unwanted cardiac events. This is one of the most important concerns of cardiologists.
F Ebrahimzadeh, M Salehi Veisi, E Hajizadeh, M Namdari   +3 more
doaj  

Coronary Spasm Due to Pulsed Field Ablation: A State‐of‐the‐Art Review

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT With the ever‐growing population of patients undergoing cardiac ablation with pulsed electric fields, there is a need to understand secondary effects from the therapy. Coronary artery spasm is one such effect that has recently emerged as the subject of further investigation in electrophysiology literature.
David A. Ramirez, Kara Garrott, Ann Garlitski, Brendan Koop   +3 more
wiley   +1 more source